Vimarsana
Biggest News Aggregation in the World

Robert Manguso News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Robert Manguso. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Robert Manguso Today - Breaking & Trending Today

Nature Publishes Discovery and Preclinical Results for ABBV-CLS-484, a Potential First-in-Class PTPN2/N1 Inhibitor in Cancer Immunotherapy - Vimarsana News

Nature Publishes Discovery and Preclinical Results for ABBV-CLS-484, a Potential First-in-Class PTPN2/N1 Inhibitor in Cancer Immunotherapy

Published: October 4, 2023

NORTH CHICAGO, Ill. and SOUTH SAN FRANCISCO, Calif., Oct. 4, 2023 /PRNewswire/ -- AbbVie , the Broad Institute of MIT and Harvard, and Calico Life Sciences today announced the publication in...

Source: marketscreener.com
Related Topics:
United StatesChristina BaumgartnerRobert MangusoHarvard Medical SchoolCalico Life SciencesHospital CenterCancer ResearchBroad InstituteExchange CommissionMarcia PaddockCalico Led PhaseMassachusetts General Hospital CenterHarvard MedicalAllergan AestheticsPrivate Securities Litigation Reform ActQuarterly ReportsPublished October
AbbVie's oral cancer drug trial shows it may provide 'anti-tumor immunity' - Vimarsana News

AbbVie's oral cancer drug trial shows it may provide 'anti-tumor immunity'

Published: October 4, 2023

Positive preclinical data for AbbVie's new oral cancer medication, ABBV-CLS-484, shows it 'enhances anti-tumor immunity.'

Source: beckershospitalreview.com
Related Topics:
United StatesRobert MangusoCancer ResearchHospital CenterCalico Life SciencesHarvard Medical SchoolBroad InstituteCalico LifeMassachusetts General Hospital CenterHarvard Medical